Funded Startups in Jupiter
Jupiter’s most recent disclosed rounds show a wide funding spread: the largest disclosed amount is Healing Realty Trust’s $25M round on 2024-06-18, while m…
Jupiter’s most recent disclosed rounds show a wide funding spread: the largest disclosed amount is Healing Realty Trust’s $25M round on 2024-06-18, while most other disclosed amounts cluster much lower, with only BioCurity Pharmaceuticals at $80K (2022-04-08) and Poiesis Medical at $200K (2021-05-20) standing out on the low end. The largest disclosed round is materially above the next-largest disclosed amounts shown (Safety Shot’s $11M on 2025-07-21 and BioRestorative Therapies’ $5M on 2026-02-11).
The 11 rows shown concentrate in a multi-year window (2021-05-20 through 2026-02-11) with a notable mid-period cluster around 2024, including Safety Shot ($3M on 2024-09-04 and $25M on 2024-06-18 for Healing Realty Trust nearby) and Dyadic International ($6M on 2024-03-11). Sector-wise, Biotechnology and Health Care each appear multiple times (Biotechnology: BioRestorative Therapies, Dyadic International, Myosin Therapeutics, BioCurity Pharmaceuticals = 4; Health Care: Safety Shot, Poiesis Medical = 2, plus “Health Care” labeled Safety Shot). Stages are also hard to normalize: 3 entries are marked “undisclosed” and 2 are “Series Unknown,” so 5 of 11 rows do not provide a specific stage label.
Most recent rounds
11 shownRelated listings
Frequently asked
Which disclosed round is the outlier in Jupiter, and how far above the rest does it sit?
Healing Realty Trust’s $25M on 2024-06-18 is the largest disclosed amount in the table and is substantially above the next-largest disclosed amounts shown: Safety Shot at $11M (2025-07-21) and BioRestorative Therapies at $5M (2026-02-11). On the low end, the smallest disclosed amount is Poiesis Medical at $200K (2021-05-20).
How concentrated are rounds in time within the most recent year shown?
Within the most recent 12 months of the latest row (from 2025-02-11 to 2026-02-11), the table shows BioRestorative Therapies at $5M (2026-02-11), Safety Shot at $11M (2025-07-21), and Scenthound marked “undisclosed” (2025-10-10). That’s three dated entries in roughly that year, with one additional undiscosed/private-equity label in the same window.
Are any sectors over-represented among these Jupiter-funded companies?
Biotechnology is the most frequent sector in the 11 rows, appearing 4 times: BioRestorative Therapies (2026-02-11, $5M), Dyadic International (2024-03-11, $6M), Myosin Therapeutics (2023-03-14, undisclosed), and BioCurity Pharmaceuticals (2022-04-08, $80K). Health Care appears 2 times via Safety Shot (2025-07-21, $11M and 2024-09-04, $3M) and Poiesis Medical (2021-05-20, $200K).
What stage labeling pattern makes it harder to compare deal sizes by stage?
Stage information is missing or non-specific for 5 of 11 rows: 3 are “undisclosed” amounts (Scenthound 2025-10-10; El Sol 2023-05-19; InsurePay 2022-04-06) and 2 are “Series Unknown” (BioRestorative Therapies 2026-02-11; Safety Shot 2025-07-21). As a result, multiple large or recent dates cannot be cleanly mapped to a consistent stage label.
Do any repeated companies or multi-round entities suggest a follow-on pattern?
Safety Shot appears twice with two different disclosed rounds: $11M on 2025-07-21 and $3M on 2024-09-04, both labeled “Series Unknown.” Other entities repeat less directly in the table (single entries for BioRestorative Therapies, Healing Realty Trust, Dyadic International, El Sol, Myosin Therapeutics, BioCurity Pharmaceuticals, InsurePay, and Poiesis Medical).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.